What is the initial test for suspected Cytomegalovirus (CMV) infection in a pregnant woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Suspected CMV Infection in Pregnant Women

For suspected CMV infection in pregnant women, the initial diagnostic test should be CMV immunoglobulin G (IgG) and IgM antibody testing with IgG avidity testing when applicable. 1, 2

Initial Serologic Testing Algorithm

  1. First-line testing:

    • CMV IgG and IgM antibody testing
    • IgG avidity testing (if IgG positive)
  2. Interpretation of results:

    • IgM negative and IgG negative: No evidence of CMV infection
    • IgM positive and IgG positive with low avidity: Suggests primary CMV infection within the past 3-4 months
    • IgM positive and IgG positive with high avidity: Suggests non-primary infection (reactivation or reinfection)
    • IgG positive, IgM negative with high avidity: Past infection, low risk of congenital transmission

Follow-up Testing Based on Initial Results

  • If primary infection is suspected (IgM positive and IgG positive with low avidity, or IgG seroconversion):

    • Amniocentesis with PCR for CMV DNA is the best confirmatory test for fetal infection 1
    • Optimal timing: after 21 weeks gestation and >6 weeks from maternal infection 1
  • If results are inconclusive:

    • Serial serologic testing may be helpful
    • High CMV IgM antibody titer is a strong predictor of low IgG avidity, suggesting primary infection 3

Ultrasound Monitoring

  • If CMV infection is confirmed or strongly suspected, ultrasound monitoring every 2-3 weeks is recommended to detect:
    • Echogenic fetal bowel
    • Cerebral calcifications
    • Microcephaly
    • Ventriculomegaly
    • Hydrops fetalis
    • Intrauterine growth restriction 4, 5

Important Considerations and Pitfalls

  • False negatives can occur: A negative maternal CMV IgM in the second trimester cannot definitively exclude congenital CMV infection 6

  • Timing matters: IgM antibodies may become negative within weeks to months after primary infection, potentially missing infections that occurred early in pregnancy 7, 6

  • Avidity testing is time-sensitive:

    • Low avidity (<40%) indicates primary infection within the last 20 weeks with high reliability 7
    • Intermediate avidity typically excludes primary infection within the last 12 weeks 7
  • Risk assessment: Primary CMV infection in early pregnancy carries the highest risk for congenital CMV and adverse fetal outcomes 5

  • Testing limitations: CMV IgG avidity testing may not be widely available in all laboratories in the United States 3

Prevention During Pregnancy

While not directly related to testing, all pregnant women should be counseled on hygiene-based preventive measures, especially those in regular contact with young children:

  • Thorough handwashing after contact with young children
  • Avoiding sharing food, drinks, or utensils with young children
  • Avoiding contact with saliva and urine of young children 4, 5

Remember that early detection is crucial, as the risk of harm to the fetus is greatest following primary CMV infection in early pregnancy, and antiviral treatment may be considered in confirmed cases of fetal infection 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CMV Infection Management During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Maternal Cytomegalovirus (CMV) Serology: The Diagnostic Limitations of CMV IgM and IgG Avidity in Detecting Congenital CMV Infection.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society, 2024

Research

The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.